US EditionUS trade tribunal to consider new Apple Watch import ban
- The U.S. International Trade Commission announced a new proceeding to assess a potential ban on imports of Apple's updated smartwatches due to a patent dispute with Masimo, a medical monitoring company.
- A jury in Santa Ana found that Apple owes Masimo $634 million for infringing its patents related to blood-oxygen measurement technology.
- Apple argues that the case is meritless and claims that Masimo copied its design for the complaint.
- Masimo has filed multiple lawsuits against Apple for patent infringement and trade-secret theft, continuing a contentious battle.
10 Articles
10 Articles
[Digital Daily Reporter Kim Moon-ki] On the 14th (local time), a jury in a California federal court ruled that Apple infringed Masimo's patents and ordered Apple to pay $634 million in damages. On the same day, the International Trade Commission (ITC) announced that it would re-examine whether to ban the import of the Apple Watch, pushing the dispute over the two companies' blood oxygen measurement technology into a phase where it faces pressure…
Apple hit with $634 million verdict in Apple Watch patent fight with Masimo
A federal jury in California has sided with Masimo in a patent battle with Apple over Apple Watch's blood oxygen feature. The jury awarded Masimo $634 million in damages and concluded that Apple infringed on a Masimo patent covering low power pulse oximeter features. As explained by Daily Journal, much of the case centered on whether Apple Watch can be categorized as a "patient monitor" per Masimo's patent. more . . .
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
